Content » Vol 64, Issue 5

Thalidomide treatment of prurigo nodularis

Winkelmann RK, Connolly SM, Doyle JA, Padilha-Goncalves A.
DOI: 10.2340/0001555564412417


Four patients with classic recalcitrant prurigo nodularis had symptomatic and physical responses to thalidomide with remissions. Three of the four patients had increased IgE levels that decreased during therapy. In two patients, short-term treatment (2 to 3 months) was not sufficient to produce remission, but retreatment was effective. Two patients had long-term remission with more than 6 months of treatment. No significant side effects occurred.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.